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Round Table
The work of the Commission on Macroeconomics and Health
A central recommendation of the Commission is that both donor countries and developing countries should greatly increase their
investments in the health sector. The Bulletin asked three members of the Commission if they were optimistic that these new resources
would be made available. And if substantial additional resources did indeed become available were they confident that they would be
well spent and achieve large and sustainable improvements in health.
More funds for health: the challenge facing
recipient countries
Anne Mills1
The Report of the Commission on Macroeconomics and Healthmakes a
strong case for a substantial increase in investments in health
sector development. However, as the Report recognizes, we
should not ignore the challenges of ensuring that any additional
funds are spent effectively. This will require new ways of
working on both sides of the donor–recipient country
partnership. Here, I want to focus on the challenges that
recipient countries will face. This focus should not be
interpreted as implying that there are no difficulties associated
with the aid instruments — clearly there are — but I will leave
others to address them.
A major area of emphasis in the thinking adopted by
WorkingGroup 5 of theCommission onMacroeconomics and
Health was directed towards achieving a better understanding
of the ‘‘constraints’’ to improving health outcomes and how
such constraints might be overcome. Constraints were
conceived to be conditions that hamper efforts to scale up
the provision of effective interventions. Following this
reasoning, we developed a typology of constraints (1) and
examined evidence for strategies that can ‘‘buy out’’ or
otherwise ameliorate constraints (2). In addition, case studies
were prepared on Chad (3), the Indian states of Karnataka and
Tamil Nadu (4), and the United Republic of Tanzania (5). We
classified factors that constrain the expansion of services into
the following categories, according to the area in which they
operate: community and household; health services delivery;
health sector policy and strategic management; overall public
policy; and environmental characteristics. Subsequently, we
examined the extent to which the constraints could be bought
out by additional funds.
Lack of money is often a governing constraint, especially
at the peripheral level, and any attempt to scale up will require
significant increases in expenditure. However, the fact that
progress is not possible without money does not mean that it is
assured if money becomes available. Without a health system
that can usemoney well, spending will notmerely be inefficient
— it may be useless, or conceivably counterproductive. Most
of the world’s poorest people lack access to an adequate health
system, and this limits all efforts to scale up the provision of
effective interventions. Inmany cases these systemic problems
will become governing restraints if spending is quickly
increased, driving the marginal benefit of spending on
materials or staff to zero.
The removal of structural constraints and the building of
new management and service delivery capacity are thus
necessary precursors to the scaling up of health interventions.
But this does not mean that the need for a commitment to
greatly increased funding is deferred or lessened. Instead,
money must be used immediately to remove constraints as
quickly as possible. There must be system-wide spending in
order to make progress, with a deliberate focus on careful
phasing of investments that will increase absorptive capacity.
Historically, one way of avoiding the problems of limited
capacity has been to adopt a ‘‘vertical’’ approach to a particular
intervention or family of interventions. There is great value in
the concentration of expertise and commitment that drives
such approaches when they are successful. However, such
approaches are an adjunct to the broader health service rather
than an alternative to it and, in the context of greatly increased
coverage of a significant number of interventions, the benefits
of overall strengthening are clear. When spread across a
number of interventions, the costs of the three major
improvements needed — expanded physical infrastructure,
improved training and performance of health workers and
managers, and strengthened links between the health system
and communities — will be smaller than the costs of trying to
bypass the problems of limited capacity.
Finally, it is important to emphasize that our knowledge
on how best to scale up health care services, particularly in the
most constrained countries, is limited, and that research on this
is badly needed. It is also quite possible that many successful
experiences are being ignored by experts simply because the
settings in which they take place are not well served by
mechanisms for communicating and disseminating results.
There is thus a need for both further research and for better
ways of exchanging ideas on best practice. n
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Additional resourceswill mean better health
K.Y. Amoako1
There is no doubt inmymind that developing countries should
increase their investments in their health sectors, a key
component of moves to increase the quality of life and reduce
the poverty of their citizens as well as to promote economic
growth. For too long, a high burden of preventable disease has
been a major handicap to the economic performance of poor
countries, especially in Africa, as well as taking a high human
toll on their populations. In addition to the perennial problems
that Africa suffers frommalaria, tuberculosis, malnutrition and
vaccine-preventable childhood diseases, it is also the region
worst affected by the global HIV/AIDS pandemic, which is
killing millions of its people, reversing a generation-long trend
of increased life expectancy, and seriously harming economic
prospects. Overcoming the diseases of poverty will be an
essential and significant step towards meeting Africa’s
international development goals.
Over the past decade, both public and private
expenditure on health have increased inAfrica. As a percentage
of GDP, the continent’s health expenditure approximates the
global average. But in objective terms, the amounts involved
remain far too small, especially in view of the costs of treating
HIV/AIDS, even with the recent welcome reductions in the
price of antiretroviral treatments. There is a general consensus
that Africa needs a major increase in investment in health
sector development.
I am optimistic that the required new resources, as
recommended by theReport of the Commission onMacroeconomics and
Health, will be made available, will be well spent, and will achieve
large and sustainable improvements in health. Many African
countries accept the need to mobilize more resources, and it is a
matter of principle and effectiveness that the first dollar in
additional spending should come from domestic rather than
donor sources. However, the international community will have
to meet the greater part of the bill. Best practice development
cooperationmodalities, such as theNewPartnership forAfrica’s
Development, provide a mechanism for effective joint action
towards these mutually agreed and mutually beneficial goals.
Achieving global health is a global public good: it is in everyone’s
interests to contain and eliminate infectious agents such as drug-
resistant strains of TB and HIV.
As well as a resource constraint, Africa faces a severe
capacity constraint. Health systems need to be strengthened
from the ground up, so that the additional resources proposed
by the Commission can be utilized effectively. As prerequi-
sites, this requires peace and improved governance, as a
foundation for building the capacities of health institutions,
training more health professionals (and retaining those who
have been trained), and establishing partnerships between
civil society and the private sector. Fortunately, more and
more developing countries, including many in Africa, are
moving in this direction. We witness greater transparency in
public expenditure and budgetary decisions, ensuring greater
compatibility between spending allocations and disburse-
ments, and more effective monitoring by civil society groups.
I look forward to better funding for health research, improved
medical care, more and better drugs, and more modern health
facilities, all of which will contribute to better health, longer
and more productive lives, and steady progress in overcoming
poverty. n
Increased health investment: a normative
path or a mirage?
Takatoshi Kato2
In my view, the Report of the Commission on Macroeconomics and
Health has succeeded in presenting a coherent normative path
for solving the worsening health conditions that prevail in
many low-income developing countries. The logical frame-
work adopted in the Report is strong enough to convince
sceptics that, if maximum contributions are obtained from all
stakeholders of low-income countries, donor countries, and
international institutions, investing in health can make this
world truly different from what it is today.
There is no question that the end objective of theReport’s
proposals is desirable. Nevertheless, translation of its vision
into results is by no means certain; and some individuals might
even claim that it is not realistic.
I can think of several reasons why a nationwide close-to-
client (CTC) system (health centres, health posts, and outreach
services from these facilities), as proposed by the Commission
in itsReport, could turn out to be something like a mirage. First,
the enormous human resources needed, clearly a ‘‘must’’ for
making the system operative, might not be realistically
available, even in the medium term. Second, establishing a
nationwide CTC system requires extraordinary dedication by
the governments of low-income developing countries and
presents them with a dilemma: such governments might not
feel inclined to take up the challenge involved unless they are
sufficiently convinced they can depend upon secular flows of
enormously scaled-up donor funding.
There are other criticisms that can be raised. For
example, examining the situation from the point of view of
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the donors, we find that current domestic health expenditures
in G7 countries are around 10% of their GDP (ranging from
6.7% in the United Kingdom to 13.0% in the USA),
according to the 2001 World Development Indicators. Thus,
G7 donor countries that scale up by 0.1% of GDP their
investments in health care in low-income developing
countries (as proposed by the Commission) will be faced
with an additional annual bill of roughly 1% of their existing
domestic expenditures on health. I have no idea how the
electorates of G7 countries will react to this idea. The Report
estimates conservatively that by 2015 an economic gain of at
least US$ 180 billion per year will result from the scaled-up
annual donor contributions that it is proposing. Those
benefits would accrue not only to people in low-income
developing countries but also to the global community at
large. In this context, it is important that taxpayers in G7
countries be made aware of the tangible and direct benefits
that they will derive if the Commission’s recommendations
are followed by their governments.
Now that the Report has been published, its recommen-
dations need to be widely disseminated so that most countries
can be inspired into action and support its vision. Luckily, there
will be ample of opportunities for this to happen in 2002. The
International Conference on Financing for Development, to
be held on 18–22 March in Monterrey, Mexico, is sure to
receive worldwide publicity; it will be an ideal opportunity to
draw the attention of world leaders to the findings of theReport.
And, on a personal level, I will be attending the Annual
Meeting of the Board ofGovernors of the AsianDevelopment
Bank, in Shanghai, China, inMay, and will take this opportunity
to introduce to a wider Asian audience to the key messages of
the Report. n
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